Showing results (111-120 of 830) with videos related to
Sort By:
Pageof 83
Pharmacogenetics|November 20, 2002
Pharmacogenetic investigation of smoking cessation treatmentCaryn Lerman, Peter G Shields, E Paul Wileyto, et al.Pharmacogenetics|November 20, 2002
Coinheritance of variant UDP-glucuronosyl transferase 1A1 gene and glucose-6-phosphate dehydrogenase deficiency in adults with hyperbilirubinemiaMay-Jen Huang, Yi-Chu Yang, Sien-Sing Yang, et al.Pharmacogenetics|November 3, 2001
Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancerD E Bamber, A A Fryer, R C Strange, et al.Pharmacogenetics|November 3, 2001
The G to C polymorphism at -174 of the interleukin-6 gene is rare in a Southern Chinese populationR Zhai, G Liu, C Yang, et al.Pharmacogenetics|November 3, 2001
Genetic polymorphisms of microsomal and soluble epoxide hydrolase and the risk of Parkinson's diseaseF M Farin, P Janssen, S Quigley, et al.Pharmacogenetics|November 3, 2001
Functional evaluation of cytochrome P450 2D6 with Gly42Arg substitution expressed in Saccharomyces cerevisiaeD Tsuzuki, C Takemi, S Yamamoto, et al.Pharmacogenetics|November 3, 2001
Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variantsJ E Tanus-Santos, M Desai, D A FlockhartPharmacogenetics|November 3, 2001
In-vitro analysis of the contribution of CYP2D6.35 to ultra-rapid metabolismD Allorge, J Harlow, O Boulet, et al.Pharmacogenetics|October 3, 2002
Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humansSilke Vogelgesang, Ingolf Cascorbi, Eike Schroeder, et al.Pharmacogenetics|October 3, 2002
Contributions of CYP2D6, CYP2C9 and CYP2C19 to the biotransformation of E- and Z-doxepin in healthy volunteersJulia Kirchheiner, Ingolf Meineke, Gunnar Müller, et al.Pageof 83